Form 4: Cardlytics Director Jonathan Edward Francis Acquires 11,000 Restricted Stock Units

Director Jonathan Edward Francis acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, according to a Form 4 filing.

Summary

• On May 20, 2025, Jonathan Edward Francis, a director of Cardlytics, Inc., acquired 11,000 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
• The RSUs will vest in full on the one-year anniversary of the grant date, provided Francis remains a director of Cardlytics on that date.
• Following the transaction, Francis beneficially owns 11,000 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to director compensation. The acquisition of RSUs can be seen as a positive sign, but it's not a major event.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs will vest in full on the one-year anniversary of the grant date, provided the Reporting Person remains a director of the Issuer on such vesting date.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can influence investor sentiment.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Cardlytics, Director, Jonathan Edward Francis, Restricted Stock Units, RSU, Form 4, Beneficial Ownership, CDLX